SCHEMBL23320355

SCHEMBL23320355

COc1cc(-n2nc3cc(N)ccc3c2C#N)ccn1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MDM4 O15151 1/20 0.36
▸ CHEK1 O14757 1/20 0.35
▸ AURKA O14965 1/20 0.35
▸ CSNK1A1 P48729 1/20 0.35
▸ CDK8 P49336 1/20 0.35
▸ NEK2 P51955 1/20 0.35
▸ LIMK1 P53667 1/20 0.35
▸ CDK5 Q00535 1/20 0.35
▸ DYRK1A Q13627 1/20 0.35
▸ CLK4 Q9HAZ1 1/20 0.35
▸ MEN1 O00255 5/20 0.34
▸ KMT2A Q03164 5/20 0.34
▸ ALDH1A1 P00352 4/20 0.34
▸ MAPT P10636 4/20 0.34
▸ NPC1 O15118 4/20 0.34
▸ KDM4E B2RXH2 3/20 0.34
▸ RAB9A P51151 3/20 0.34
▸ SMN1; SMN2 Q16637 2/20 0.34
▸ GAA P10253 2/20 0.34
▸ HSD17B10 Q99714 2/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30943209 1.00 MDM4 (0.36) MDM4CHEK1AURKACSNK1A1CDK8
SCHEMBL23320403 0.77 LRRK2 (0.31) MAT2A
SCHEMBL23320405 0.76 LRRK2 (0.37) JAK2JAK1CYP17A1AAK1
SCHEMBL29232474 0.76 JAK2 (0.33) MAT2AJAK2JAK1
SCHEMBL23320374 0.76 CHEK1 (0.58) MDM4CHEK1AURKACSNK1A1CDK8
SCHEMBL30943196 0.73 NAMPT (0.45) —
SCHEMBL23320377 0.73 NAMPT (0.45) —
SCHEMBL30943207 0.68 GAK (0.36) GAALOXLOXL2MAT2ACYP17A1
SCHEMBL23320397 0.68 GAK (0.36) GAALOXLOXL2MAT2ACYP17A1
SCHEMBL68300 0.67 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12263159-B2 Fused ring compound having urea structure Sanford Burnham Prebys Medical Discovery Institute (US) 2025-04-01 — — US disclosed
US-20240285597-A1 FUSED RING COMPOUND HAVING UREA STRUCTURE DAIICHI SANKYO COMPANY LIMITED (JP) 2024-08-29 — — US disclosed
CN-112654608-B Fused ring compound having urea structure 桑福德伯纳姆普利斯医学发现研究所 2024-05-07 — — CN disclosed
US-11918568-B2 Fused ring compound having urea structure Sanford Burnham Prebys Medical Discovery Institute (US) 2024-03-05 — — US disclosed
EP-3818053-B1 FUSED RING COMPOUND HAVING UREA STRUCTURE SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INST (US) 2023-03-29 — — EP disclosed
US-20210361636-A1 FUSED RING COMPOUND HAVING UREA STRUCTURE DAIICHI SANKYO COMPANY LIMITED (JP) 2021-11-25 — — US disclosed
EP-3818053-A1 FUSED RING COMPOUND HAVING UREA STRUCTURE Sanford Burnham Prebys Medical Discovery Institute (US) 2021-05-12 — — EP disclosed
CN-112654608-A Condensed ring compounds having urea structure 桑福德伯纳姆普利斯医学发现研究所 2021-04-13 — — CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12263159-B2 Fused ring compound having urea structure NAMPT, NME4, NDUFAB1 MDM4 4365/4885CHEK1 3922/4885AURKA 3130/4885
US-20210361636-A1 FUSED RING COMPOUND HAVING UREA STRUCTURE NAMPT, NME4, ABAT MDM4 4361/4885CHEK1 3923/4885AURKA 3060/4885
US-11918568-B2 Fused ring compound having urea structure NAMPT, NME4, ABAT MDM4 4361/4885CHEK1 3923/4885AURKA 3060/4885
US-20240285597-A1 FUSED RING COMPOUND HAVING UREA STRUCTURE NAMPT, NME4, NDUFAB1 MDM4 4365/4885CHEK1 3922/4885AURKA 3130/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback